Yasuhiro Masubuchi

1.5k total citations
39 papers, 1.2k citations indexed

About

Yasuhiro Masubuchi is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Yasuhiro Masubuchi has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmacology, 21 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Yasuhiro Masubuchi's work include Pharmacogenetics and Drug Metabolism (31 papers), Drug Transport and Resistance Mechanisms (21 papers) and Inflammatory mediators and NSAID effects (10 papers). Yasuhiro Masubuchi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (31 papers), Drug Transport and Resistance Mechanisms (21 papers) and Inflammatory mediators and NSAID effects (10 papers). Yasuhiro Masubuchi collaborates with scholars based in Japan, Czechia and United States. Yasuhiro Masubuchi's co-authors include Toshiharu Horie, Shintaro Nakayama, Shizuo Narimatsu, Atsushi Ose, Tokuji Suzuki, Haruka Saito, Ryuichiro Nishigaki, Shoichi Fujita, Hirokazu Doi and Hiromi Iwasaki and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Yasuhiro Masubuchi

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuhiro Masubuchi Japan 17 783 344 329 152 129 39 1.2k
Jean-Pierre Flinois France 21 805 1.0× 433 1.3× 405 1.2× 98 0.6× 78 0.6× 31 1.4k
Raimund M. Peter United States 18 993 1.3× 425 1.2× 349 1.1× 205 1.3× 72 0.6× 21 1.5k
Gilles Labbe France 21 819 1.0× 286 0.8× 469 1.4× 144 0.9× 358 2.8× 29 1.6k
J. A. Hinson United States 17 737 0.9× 262 0.8× 301 0.9× 106 0.7× 64 0.5× 26 1.3k
A. B. Renwick United Kingdom 24 857 1.1× 341 1.0× 347 1.1× 137 0.9× 39 0.3× 34 1.4k
L. Vereczkey Hungary 21 547 0.7× 358 1.0× 341 1.0× 182 1.2× 81 0.6× 89 1.4k
C. Riché France 18 585 0.7× 454 1.3× 386 1.2× 239 1.6× 62 0.5× 51 1.3k
P Lettéron France 20 520 0.7× 217 0.6× 419 1.3× 109 0.7× 345 2.7× 30 1.4k
M Hashimoto Japan 11 742 0.9× 272 0.8× 191 0.6× 114 0.8× 94 0.7× 20 1.1k
Daniel Fau France 19 519 0.7× 159 0.5× 457 1.4× 66 0.4× 158 1.2× 31 1.3k

Countries citing papers authored by Yasuhiro Masubuchi

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Masubuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Masubuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Masubuchi more than expected).

Fields of papers citing papers by Yasuhiro Masubuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Masubuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Masubuchi. The network helps show where Yasuhiro Masubuchi may publish in the future.

Co-authorship network of co-authors of Yasuhiro Masubuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Masubuchi. A scholar is included among the top collaborators of Yasuhiro Masubuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Masubuchi. Yasuhiro Masubuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masubuchi, Yasuhiro, et al.. (2024). Metabolism-dependent inhibition of CYP2E1 by isoniazid, a mediator of idiosyncratic liver injury. Chemico-Biological Interactions. 400. 111160–111160. 4 indexed citations
2.
Masubuchi, Yasuhiro, et al.. (2023). Time-Dependent Inhibition of CYP1A2 by Stiripentol and Structurally Related Methylenedioxyphenyl Compounds via Metabolic Intermediate Complex Formation. Drug Metabolism and Disposition. 52(1). 63–68. 2 indexed citations
3.
Masubuchi, Yasuhiro & Shinji Kondo. (2016). Inactivation of CYP3A4 by Benzbromarone in Human Liver Microsomes. Drug Metabolism Letters. 10(1). 16–21. 3 indexed citations
4.
Masubuchi, Yasuhiro & Toshiharu Horie. (2007). Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs. Critical Reviews in Toxicology. 37(5). 389–412. 76 indexed citations
5.
Masubuchi, Yasuhiro, et al.. (2007). Down-Regulation of Hepatic Cytochrome P450 Enzymes in Rats with Trinitrobenzene Sulfonic Acid-Induced Colitis. Drug Metabolism and Disposition. 36(3). 597–603. 25 indexed citations
6.
Masubuchi, Yasuhiro, et al.. (2006). Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones. Toxicology. 222(3). 233–239. 79 indexed citations
7.
Masubuchi, Yasuhiro. (2006). Metabolic and Non-Metabolic Factors Determining Troglitazone Hepatotoxicity: A Review. Drug Metabolism and Pharmacokinetics. 21(5). 347–356. 89 indexed citations
8.
Masubuchi, Yasuhiro, et al.. (2004). Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. Journal of Hepatology. 42(1). 110–116. 263 indexed citations
9.
Masubuchi, Yasuhiro & Toshiharu Horie. (2004). ENDOTOXIN-MEDIATED DISTURBANCE OF HEPATIC CYTOCHROME P450 FUNCTION AND DEVELOPMENT OF ENDOTOXIN TOLERANCE IN THE RAT MODEL OF DEXTRAN SULFATE SODIUM-INDUCED EXPERIMENTAL COLITIS. Drug Metabolism and Disposition. 32(4). 437–441. 45 indexed citations
10.
Doi, Hirokazu, et al.. (2002). Chemiluminescence associated with the oxidative metabolism of salicylic acid in rat liver microsomes. Chemico-Biological Interactions. 140(2). 109–119. 46 indexed citations
11.
Masubuchi, Yasuhiro, Atsushi Ose, & Toshiharu Horie. (2002). Diclofenac-Induced Inactivation of CYP3A4 and Its Stimulation by Quinidine. Drug Metabolism and Disposition. 30(10). 1143–1148. 41 indexed citations
12.
Masubuchi, Yasuhiro, Shintaro Nakayama, & Toshiharu Horie. (2002). Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology. 35(3). 544–551. 150 indexed citations
13.
Yamamoto, Kyoko, et al.. (2001). Rat Liver Microsomal Lipid Peroxidation Produced during the Oxidative Metabolism of Ethacrynic Acid. Pharmacology & Toxicology. 88(4). 176–180. 12 indexed citations
14.
Gao, Feng, et al.. (2001). Protective effect of a synthetic analog of prostaglandin E1 on the small intestinal damage induced by the administration of methotrexate to rats. Journal of Pharmaceutical Sciences. 90(8). 1040–1048. 13 indexed citations
15.
Narimatsu, Shizuo, et al.. (1999). Biphasic Kinetics of Imipramine N-Oxidation in Rat Brain Microsomes.. Biological and Pharmaceutical Bulletin. 22(3). 253–256. 4 indexed citations
16.
Narimatsu, Shizuo, et al.. (1999). Contribution of Flavin-Containing Monooxygenase and Cytochrome P450 to Imipramine N-Oxidation in Rat Hepatic Microsomes.. Biological and Pharmaceutical Bulletin. 22(6). 567–571. 8 indexed citations
17.
Masubuchi, Yasuhiro, et al.. (1998). Structural Requirements for the Hepatotoxicity of Nonsteroidal Anti-inflammatory Drugs in Isolated Rat Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 287(1). 208–213. 75 indexed citations
18.
Suzuki, Tokuji, et al.. (1993). Kinetic analysis of mutual metabolic inhibition of lidocaine and propranolol in rat liver musomes. Biochemical Pharmacology. 45(7). 1528–1530. 10 indexed citations
19.
Masubuchi, Yasuhiro, et al.. (1993). Participation of the CYP2D subfamily in lidocaine 3-hydroxylation and formation of a reactive metabolite covalently bound to liver microsomal protein in rats. Biochemical Pharmacology. 46(10). 1867–1869. 12 indexed citations
20.
Masubuchi, Yasuhiro, et al.. (1992). Enzymatic basis for the non-linearity of hepatic elimination of propranolol in the isolated perfused rat liver. Biochemical Pharmacology. 44(12). 2281–2288. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Pierre Flinois Breakdown of academic impact, for papers by Raimund M. Peter Breakdown of academic impact, for papers by Gilles Labbe Breakdown of academic impact, for papers by J. A. Hinson Breakdown of academic impact, for papers by A. B. Renwick Breakdown of academic impact, for papers by L. Vereczkey Breakdown of academic impact, for papers by C. Riché Breakdown of academic impact, for papers by P Lettéron Breakdown of academic impact, for papers by M Hashimoto Breakdown of academic impact, for papers by Daniel Fau
Rankless by CCL
2026